A Time of Promise, a Time of Promises: Ethical Issues in Advancing Psychopharmacological Research
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Tierney E, Aman M, Stout D, Pappas K, Eugene Arnold L, Vitiello B Psychopharmacology (Berl). 2006; 191(1):149-57.
PMID: 17123125 DOI: 10.1007/s00213-006-0604-z.
References
1.
Kleiman M
. The 'brain disease' idea, drug policy and research ethics. Addiction. 2003; 98(7):871-2.
DOI: 10.1046/j.1360-0443.2003.00454.x.
View
2.
Roberts L, Warner T, Brody J
. Perspectives of patients with schizophrenia and psychiatrists regarding ethically important aspects of research participation. Am J Psychiatry. 2000; 157(1):67-74.
DOI: 10.1176/ajp.157.1.67.
View
3.
Roberts L
. Evidence-based ethics and informed consent in mental illness research. Arch Gen Psychiatry. 2000; 57(6):540-2.
DOI: 10.1001/archpsyc.57.6.540.
View
4.
Roberts L, Warner T, Anderson C, Smithpeter M, Rogers M
. Schizophrenia research participants' responses to protocol safeguards: recruitment, consent, and debriefing. Schizophr Res. 2004; 67(2-3):283-91.
DOI: 10.1016/S0920-9964(03)00101-4.
View
5.
Maubach K
. Psychiatric drug discovery and development. Expert Opin Investig Drugs. 2003; 12(9):1571-5.
DOI: 10.1517/13543784.12.9.1571.
View